Sign in
4

Changes in Ownership

AIM ImmunoTech Inc. Filed Acc 0001613377-19-000003

Exec. Vice Chairman/CEO/Pres. acquired 552,500 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
EQUELS THOMAS K. Exec. Vice Chairman/CEO/Pres. 2019-03-18 Conversion +325,000 1,136,707 D
EQUELS THOMAS K. Exec. Vice Chairman/CEO/Pres. 2019-05-08 Conversion +227,500 1,364,207 D
Loading xslF345X03/primary_doc.xml…